when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Obesity · news · pharmadog

← back to Obesity

News mentioning Obesity

367 stories

Jun 1, 26STAT+: Pharmalittle: We’re reading about pancreatic and lung cancer drugs, China biotech growth, and morestat

Jun 1, 26CDC says containing the spread of Ebola is top prioritystat

Jun 1, 262026 Orphan Drugs Report: A safe(r) passage amid stormy waters?biopharma dive

Jun 1, 26STAT+: Medicare still won’t say how much covering obesity drugs will coststat

Jun 1, 26The hidden history of BPC-157, a favorite MAHA peptidestat

Jun 1, 26STAT+: No Surprises Act arbitration rule could worsen flood of provider disputesstat

May 30, 26STAT+: China competition, ‘destruction’ at FDA give agency chance to restructure, Rick Pazdur saysstat

May 30, 26STAT+: As Ebola outbreak grows, Trump administration veers from previous government playbookstat

May 29, 26STAT+: Trump administration seeks to overhaul federal grantmaking process, alarming researchersstat

May 29, 26STAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and morestat

May 29, 26STAT+: Up and down the ladder: The latest comings and goingsstat

May 29, 26Opinion: I’m a weight-loss doctor. Here’s why I worry about GLP-1 ‘microdoses’stat

May 28, 26Lilly obesity meds Foundayo and Zepbound to gain CVS coverageendpoints

May 28, 26CVS obesity drug deal puts Lilly on equal footing with Novobiopharma dive

May 27, 26AstraZeneca's breast cancer PDUFA delayed; Arrowhead aims at same obesity target as Waveendpoints

May 18, 26Design Therapeutics' Friedreich's ataxia data; Vincentage's obesity results from Chinaendpoints

May 18, 26Høeg fired in latest FDA shakeup; 20 people die after taking Amgen drugbiopharma dive

May 18, 26Regeneron immunotherapy combo comes up short in melanoma trialbiopharma dive

May 14, 26Makary’s departure and Cassidy’s tenuous Senate seatstat

May 13, 26U.S. overdose deaths fell again in 2025, but some worry about policy and drug supply changesstat

May 13, 26Lilly data point to ‘maintenance’ strategies for GLP-1 weight lossbiopharma dive

May 13, 26The ‘velocity of obesity’ aims to show which nations are slowing an epidemicstat

May 13, 26STAT+: Pharmalittle: We’re reading about FDA’s Makary resigning, a Lilly weight loss drug trial, and morestat

May 13, 26STAT+: A new kind of liver crisis is emerging in the U.S. The American diet is to blamestat

May 12, 26Lilly points to low-dose Zepbound and Foundayo as weight loss maintenance optionsendpoints

May 12, 26STAT+: Pharmalittle: We’re reading about pharma lobbying, Bristol’s deal with a Chinese partner, and morestat

May 12, 26Bristol Myers, Hengrui join forces in drugmaking alliance worth up to $15.2 billionbiopharma dive

May 12, 26Second Clinical Scenario - Progressive Disease Despite Hematocrit Controlonclive

May 12, 26A year after Vertex’s big launch, pain drug research faces a pivotal momentbiopharma dive

May 12, 26STAT+: Alcohol is wreaking havoc on U.S. public health. American society looks the other waystat

← prevpage 10 of 13next →